Transfusion

Cover image for Vol. 53 Issue 7

July 2013

Volume 53, Issue 7

Pages 1379–1621, e1–e1

  1. EDITORIAL

    1. Top of page
    2. EDITORIAL
    3. TRANSFUSION MEDICINE ILLUSTRATED
    4. CLINICAL RESEARCH FOCUS #34
    5. HOW DO I … ?
    6. TRANSFUSION COMPLICATIONS
    7. TRANSFUSION PRACTICE
    8. BLOOD DONORS AND BLOOD COLLECTION
    9. BLOOD MANAGEMENT
    10. DONOR INFECTIOUS DISEASE TESTING
    11. TRANSPLANTATION AND CELLULAR ENGINEERING
    12. BLOOD COMPONENTS
    13. BLOOD GROUP GENOMICS
    14. IMMUNE HEMATOLOGIC DISEASE
    15. HEMAPHERESIS
    16. REVIEWS
    17. LETTERS
  2. TRANSFUSION MEDICINE ILLUSTRATED

    1. Top of page
    2. EDITORIAL
    3. TRANSFUSION MEDICINE ILLUSTRATED
    4. CLINICAL RESEARCH FOCUS #34
    5. HOW DO I … ?
    6. TRANSFUSION COMPLICATIONS
    7. TRANSFUSION PRACTICE
    8. BLOOD DONORS AND BLOOD COLLECTION
    9. BLOOD MANAGEMENT
    10. DONOR INFECTIOUS DISEASE TESTING
    11. TRANSPLANTATION AND CELLULAR ENGINEERING
    12. BLOOD COMPONENTS
    13. BLOOD GROUP GENOMICS
    14. IMMUNE HEMATOLOGIC DISEASE
    15. HEMAPHERESIS
    16. REVIEWS
    17. LETTERS
  3. CLINICAL RESEARCH FOCUS #34

    1. Top of page
    2. EDITORIAL
    3. TRANSFUSION MEDICINE ILLUSTRATED
    4. CLINICAL RESEARCH FOCUS #34
    5. HOW DO I … ?
    6. TRANSFUSION COMPLICATIONS
    7. TRANSFUSION PRACTICE
    8. BLOOD DONORS AND BLOOD COLLECTION
    9. BLOOD MANAGEMENT
    10. DONOR INFECTIOUS DISEASE TESTING
    11. TRANSPLANTATION AND CELLULAR ENGINEERING
    12. BLOOD COMPONENTS
    13. BLOOD GROUP GENOMICS
    14. IMMUNE HEMATOLOGIC DISEASE
    15. HEMAPHERESIS
    16. REVIEWS
    17. LETTERS
  4. HOW DO I … ?

    1. Top of page
    2. EDITORIAL
    3. TRANSFUSION MEDICINE ILLUSTRATED
    4. CLINICAL RESEARCH FOCUS #34
    5. HOW DO I … ?
    6. TRANSFUSION COMPLICATIONS
    7. TRANSFUSION PRACTICE
    8. BLOOD DONORS AND BLOOD COLLECTION
    9. BLOOD MANAGEMENT
    10. DONOR INFECTIOUS DISEASE TESTING
    11. TRANSPLANTATION AND CELLULAR ENGINEERING
    12. BLOOD COMPONENTS
    13. BLOOD GROUP GENOMICS
    14. IMMUNE HEMATOLOGIC DISEASE
    15. HEMAPHERESIS
    16. REVIEWS
    17. LETTERS
    1. How do we integrate thromboelastography with perioperative transfusion management? (pages 1386–1392)

      Duncan MacIvor, Annette Rebel and Zaki-Udin Hassan

      Article first published online: 7 JUN 2012 | DOI: 10.1111/j.1537-2995.2012.03728.x

  5. TRANSFUSION COMPLICATIONS

    1. Top of page
    2. EDITORIAL
    3. TRANSFUSION MEDICINE ILLUSTRATED
    4. CLINICAL RESEARCH FOCUS #34
    5. HOW DO I … ?
    6. TRANSFUSION COMPLICATIONS
    7. TRANSFUSION PRACTICE
    8. BLOOD DONORS AND BLOOD COLLECTION
    9. BLOOD MANAGEMENT
    10. DONOR INFECTIOUS DISEASE TESTING
    11. TRANSPLANTATION AND CELLULAR ENGINEERING
    12. BLOOD COMPONENTS
    13. BLOOD GROUP GENOMICS
    14. IMMUNE HEMATOLOGIC DISEASE
    15. HEMAPHERESIS
    16. REVIEWS
    17. LETTERS
    1. Residual risk of transfusion-transmitted hepatitis B virus (HBV) infection caused by blood components derived from donors with occult HBV infection in Japan (pages 1393–1404)

      Rikizo Taira, Masahiro Satake, Shun'ya Momose, Satoru Hino, Yoshiharu Suzuki, Hiroyuki Murokawa, Shigeharu Uchida and Kenji Tadokoro

      Article first published online: 4 OCT 2012 | DOI: 10.1111/j.1537-2995.2012.03909.x

    2. You have free access to this content
      Infectivity of blood products from donors with occult hepatitis B virus infection (pages 1405–1415)

      Jean-Pierre Allain, Ivanka Mihaljevic, Maria Isabel Gonzalez-Fraile, Knut Gubbe, Lene Holm-Harritshøj, Jose Maria Garcia, Ewa Brojer, Christian Erikstrup, Mona Saniewski, Lorenz Wernish, Lydia Bianco, Henrik Ullum, Daniel Candotti, Nico Lelie, Wolfram H. Gerlich and Michael Chudy

      Article first published online: 30 JAN 2013 | DOI: 10.1111/trf.12096

    3. Risks and adverse outcomes associated with emergency-release red blood cell transfusion (pages 1416–1420)

      Sudhanshu B. Mulay, Elizabeth A. Jaben, Pamela Johnson, Karafa Badjie and James R. Stubbs

      Article first published online: 15 OCT 2012 | DOI: 10.1111/j.1537-2995.2012.03922.x

    4. Modeling the transmission risk of emerging infectious diseases through blood transfusion (pages 1421–1428)

      Welling Oei, Mart P. Janssen, Cees L. van der Poel, Jim E. van Steenbergen, Sybille Rehmet and Mirjam E.E. Kretzschmar

      Article first published online: 31 OCT 2012 | DOI: 10.1111/j.1537-2995.2012.03941.x

    5. Investigating the prevalence of transfusion transmission of Plasmodium within a hyperendemic blood donation system (pages 1429–1441)

      Graham Freimanis, Mary Sedegah, Shirley Owusu-Ofori, Sanjai Kumar and Jean-Pierre Allain

      Article first published online: 31 OCT 2012 | DOI: 10.1111/j.1537-2995.2012.03943.x

  6. TRANSFUSION PRACTICE

    1. Top of page
    2. EDITORIAL
    3. TRANSFUSION MEDICINE ILLUSTRATED
    4. CLINICAL RESEARCH FOCUS #34
    5. HOW DO I … ?
    6. TRANSFUSION COMPLICATIONS
    7. TRANSFUSION PRACTICE
    8. BLOOD DONORS AND BLOOD COLLECTION
    9. BLOOD MANAGEMENT
    10. DONOR INFECTIOUS DISEASE TESTING
    11. TRANSPLANTATION AND CELLULAR ENGINEERING
    12. BLOOD COMPONENTS
    13. BLOOD GROUP GENOMICS
    14. IMMUNE HEMATOLOGIC DISEASE
    15. HEMAPHERESIS
    16. REVIEWS
    17. LETTERS
    1. The effectiveness and safety of fixed low-dose prothrombin complex concentrates in patients requiring urgent reversal of warfarin (CME) (pages 1451–1458)

      Cindy Varga, Sultan Al-Touri, Stella Papadoukakis, Stephen Caplan, Susan Kahn and Mark Blostein

      Article first published online: 15 OCT 2012 | DOI: 10.1111/j.1537-2995.2012.03924.x

    2. The effect of blood transfusion on cerebral hemodynamics in preterm infants (pages 1459–1467)

      Kosuke Koyano, Takashi Kusaka, Shinji Nakamura, Makoto Nakamura, Yukihiko Konishi, Takanori Miki, Masaki Ueno, Saneyuki Yasuda, Hitoshi Okada, Tomoko Nishida, Kenichi Isobe and Susumu Itoh

      Article first published online: 12 NOV 2012 | DOI: 10.1111/j.1537-2995.2012.03953.x

  7. BLOOD DONORS AND BLOOD COLLECTION

    1. Top of page
    2. EDITORIAL
    3. TRANSFUSION MEDICINE ILLUSTRATED
    4. CLINICAL RESEARCH FOCUS #34
    5. HOW DO I … ?
    6. TRANSFUSION COMPLICATIONS
    7. TRANSFUSION PRACTICE
    8. BLOOD DONORS AND BLOOD COLLECTION
    9. BLOOD MANAGEMENT
    10. DONOR INFECTIOUS DISEASE TESTING
    11. TRANSPLANTATION AND CELLULAR ENGINEERING
    12. BLOOD COMPONENTS
    13. BLOOD GROUP GENOMICS
    14. IMMUNE HEMATOLOGIC DISEASE
    15. HEMAPHERESIS
    16. REVIEWS
    17. LETTERS
    1. The effect of frequent whole blood donation on ferritin, hepcidin, and subclinical atherosclerosis (pages 1468–1474)

      Karlijn Peffer, Martin den Heijer, Suzanne Holewijn, Jacqueline de Graaf, Dorine W. Swinkels, André L.M. Verbeek and Femke Atsma

      Article first published online: 9 OCT 2012 | DOI: 10.1111/j.1537-2995.2012.03916.x

  8. BLOOD MANAGEMENT

    1. Top of page
    2. EDITORIAL
    3. TRANSFUSION MEDICINE ILLUSTRATED
    4. CLINICAL RESEARCH FOCUS #34
    5. HOW DO I … ?
    6. TRANSFUSION COMPLICATIONS
    7. TRANSFUSION PRACTICE
    8. BLOOD DONORS AND BLOOD COLLECTION
    9. BLOOD MANAGEMENT
    10. DONOR INFECTIOUS DISEASE TESTING
    11. TRANSPLANTATION AND CELLULAR ENGINEERING
    12. BLOOD COMPONENTS
    13. BLOOD GROUP GENOMICS
    14. IMMUNE HEMATOLOGIC DISEASE
    15. HEMAPHERESIS
    16. REVIEWS
    17. LETTERS
    1. Processed residual pump blood in cardiac surgery: the Processed Residual Blood in Cardiac surgery trial (pages 1487–1492)

      Richard Whitlock, Joseph Mathew, John Eikelboom, Ayman Mohammad Al-Saleh, Fei Yuan and Kevin Teoh

      Article first published online: 26 NOV 2012 | DOI: 10.1111/j.1537-2995.2012.03958.x

  9. DONOR INFECTIOUS DISEASE TESTING

    1. Top of page
    2. EDITORIAL
    3. TRANSFUSION MEDICINE ILLUSTRATED
    4. CLINICAL RESEARCH FOCUS #34
    5. HOW DO I … ?
    6. TRANSFUSION COMPLICATIONS
    7. TRANSFUSION PRACTICE
    8. BLOOD DONORS AND BLOOD COLLECTION
    9. BLOOD MANAGEMENT
    10. DONOR INFECTIOUS DISEASE TESTING
    11. TRANSPLANTATION AND CELLULAR ENGINEERING
    12. BLOOD COMPONENTS
    13. BLOOD GROUP GENOMICS
    14. IMMUNE HEMATOLOGIC DISEASE
    15. HEMAPHERESIS
    16. REVIEWS
    17. LETTERS
    1. Stability of Coxiella burnetii in stored human blood (pages 1493–1496)

      Gilbert J. Kersh, Rachael Priestley and Robert F. Massung

      Article first published online: 3 OCT 2012 | DOI: 10.1111/j.1537-2995.2012.03912.x

    2. The value of screening signal-to-cutoff ratios for hepatitis C virus antibody confirmation (pages 1497–1500)

      Susan L. Stramer, Roger Y. Dodd and Jaye P. Brodsky

      Article first published online: 26 NOV 2012 | DOI: 10.1111/j.1537-2995.2012.03955.x

  10. TRANSPLANTATION AND CELLULAR ENGINEERING

    1. Top of page
    2. EDITORIAL
    3. TRANSFUSION MEDICINE ILLUSTRATED
    4. CLINICAL RESEARCH FOCUS #34
    5. HOW DO I … ?
    6. TRANSFUSION COMPLICATIONS
    7. TRANSFUSION PRACTICE
    8. BLOOD DONORS AND BLOOD COLLECTION
    9. BLOOD MANAGEMENT
    10. DONOR INFECTIOUS DISEASE TESTING
    11. TRANSPLANTATION AND CELLULAR ENGINEERING
    12. BLOOD COMPONENTS
    13. BLOOD GROUP GENOMICS
    14. IMMUNE HEMATOLOGIC DISEASE
    15. HEMAPHERESIS
    16. REVIEWS
    17. LETTERS
    1. A prospective study on the efficacy of mobilization of autologous peripheral stem cells in pediatric oncohematology patients (pages 1501–1509)

      Simone Cesaro, Veronica Tintori, Francesca Nesi, Elisabetta Schiavello, Elisabetta Calore, Sandro Dallorso, Maddalena Migliavacca, Ilaria Capolsini, Raffaella Desantis, Desirèe Caselli, Franca Fagioli, Roberto Luksch, Irene Panizzolo, Gloria Tridello and Arcangelo Prete

      Article first published online: 3 OCT 2012 | DOI: 10.1111/j.1537-2995.2012.03911.x

    2. High acceptance rate of hybrid allogeneic–autologous umbilical cord blood banking among actual and potential Swiss donors (pages 1510–1519)

      Anna-Margaretha Wagner, Werner Krenger, Eva Suter, Dorra Ben Hassem and Daniel V. Surbek

      Article first published online: 15 OCT 2012 | DOI: 10.1111/j.1537-2995.2012.03921.x

  11. BLOOD COMPONENTS

    1. Top of page
    2. EDITORIAL
    3. TRANSFUSION MEDICINE ILLUSTRATED
    4. CLINICAL RESEARCH FOCUS #34
    5. HOW DO I … ?
    6. TRANSFUSION COMPLICATIONS
    7. TRANSFUSION PRACTICE
    8. BLOOD DONORS AND BLOOD COLLECTION
    9. BLOOD MANAGEMENT
    10. DONOR INFECTIOUS DISEASE TESTING
    11. TRANSPLANTATION AND CELLULAR ENGINEERING
    12. BLOOD COMPONENTS
    13. BLOOD GROUP GENOMICS
    14. IMMUNE HEMATOLOGIC DISEASE
    15. HEMAPHERESIS
    16. REVIEWS
    17. LETTERS
    1. Enhanced shear-induced platelet aggregation due to low-temperature storage (pages 1520–1530)

      Robbie K. Montgomery, Kristin M. Reddoch, Shankar J. Evani, Andrew P. Cap and Anand K. Ramasubramanian

      Article first published online: 9 OCT 2012 | DOI: 10.1111/j.1537-2995.2012.03917.x

    2. The challenges of measuring bleeding outcomes in clinical trials of platelet transfusions (pages 1531–1543)

      Lise J. Estcourt, Nancy Heddle, Richard Kaufman, Jeffrey McCullough, Michael F. Murphy, Sherrill Slichter, Erica M. Wood, Simon J. Stanworth and on behalf of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative

      Article first published online: 10 JAN 2013 | DOI: 10.1111/trf.12058

  12. BLOOD GROUP GENOMICS

    1. Top of page
    2. EDITORIAL
    3. TRANSFUSION MEDICINE ILLUSTRATED
    4. CLINICAL RESEARCH FOCUS #34
    5. HOW DO I … ?
    6. TRANSFUSION COMPLICATIONS
    7. TRANSFUSION PRACTICE
    8. BLOOD DONORS AND BLOOD COLLECTION
    9. BLOOD MANAGEMENT
    10. DONOR INFECTIOUS DISEASE TESTING
    11. TRANSPLANTATION AND CELLULAR ENGINEERING
    12. BLOOD COMPONENTS
    13. BLOOD GROUP GENOMICS
    14. IMMUNE HEMATOLOGIC DISEASE
    15. HEMAPHERESIS
    16. REVIEWS
    17. LETTERS
    1. RHD and RHCE variant and zygosity genotyping via multiplex ligation–dependent probe amplification (pages 1559–1574)

      Lonneke Haer-Wigman, Barbera Veldhuisen, Remco Jonkers, Martin Lodén, Tracey E. Madgett, Neil D. Avent, Masja de Haas and C. Ellen van der Schoot

      Article first published online: 9 OCT 2012 | DOI: 10.1111/j.1537-2995.2012.03919.x

    2. The JR blood group system (ISBT 032): molecular characterization of three new null alleles (pages 1575–1579)

      Kim Hue-Roye, Christine Lomas-Francis, Gail Coghlan, Teresa Zelinski and Marion E. Reid

      Article first published online: 15 OCT 2012 | DOI: 10.1111/j.1537-2995.2012.03930.x

  13. IMMUNE HEMATOLOGIC DISEASE

    1. Top of page
    2. EDITORIAL
    3. TRANSFUSION MEDICINE ILLUSTRATED
    4. CLINICAL RESEARCH FOCUS #34
    5. HOW DO I … ?
    6. TRANSFUSION COMPLICATIONS
    7. TRANSFUSION PRACTICE
    8. BLOOD DONORS AND BLOOD COLLECTION
    9. BLOOD MANAGEMENT
    10. DONOR INFECTIOUS DISEASE TESTING
    11. TRANSPLANTATION AND CELLULAR ENGINEERING
    12. BLOOD COMPONENTS
    13. BLOOD GROUP GENOMICS
    14. IMMUNE HEMATOLOGIC DISEASE
    15. HEMAPHERESIS
    16. REVIEWS
    17. LETTERS
    1. Postnatal outcome in neonates with severe Rhesus c compared to Rhesus D hemolytic disease (pages 1580–1585)

      Mirjam E.A. Rath, Vivianne E.H.J. Smits-Wintjens, Irene T.M. Lindenburg, Claudia C. Folman, Anneke Brand, Inge L. van Kamp, Dick Oepkes, Frans J. Walther and Enrico Lopriore

      Article first published online: 31 OCT 2012 | DOI: 10.1111/j.1537-2995.2012.03937.x

  14. HEMAPHERESIS

    1. Top of page
    2. EDITORIAL
    3. TRANSFUSION MEDICINE ILLUSTRATED
    4. CLINICAL RESEARCH FOCUS #34
    5. HOW DO I … ?
    6. TRANSFUSION COMPLICATIONS
    7. TRANSFUSION PRACTICE
    8. BLOOD DONORS AND BLOOD COLLECTION
    9. BLOOD MANAGEMENT
    10. DONOR INFECTIOUS DISEASE TESTING
    11. TRANSPLANTATION AND CELLULAR ENGINEERING
    12. BLOOD COMPONENTS
    13. BLOOD GROUP GENOMICS
    14. IMMUNE HEMATOLOGIC DISEASE
    15. HEMAPHERESIS
    16. REVIEWS
    17. LETTERS
    1. Cyclosporin A therapy on idiopathic thrombotic thrombocytopenic purpura in the relapse setting: two case reports and a review of the literature (pages 1586–1593)

      Murvet Yilmaz, Ahmet Emre Eskazan, Abdulkadir Unsal, Hakan Taninmis, Ekrem Kara, Mustafa Cetiner and Burhan Ferhanoglu

      Article first published online: 1 NOV 2012 | DOI: 10.1111/j.1537-2995.2012.03944.x

  15. REVIEWS

    1. Top of page
    2. EDITORIAL
    3. TRANSFUSION MEDICINE ILLUSTRATED
    4. CLINICAL RESEARCH FOCUS #34
    5. HOW DO I … ?
    6. TRANSFUSION COMPLICATIONS
    7. TRANSFUSION PRACTICE
    8. BLOOD DONORS AND BLOOD COLLECTION
    9. BLOOD MANAGEMENT
    10. DONOR INFECTIOUS DISEASE TESTING
    11. TRANSPLANTATION AND CELLULAR ENGINEERING
    12. BLOOD COMPONENTS
    13. BLOOD GROUP GENOMICS
    14. IMMUNE HEMATOLOGIC DISEASE
    15. HEMAPHERESIS
    16. REVIEWS
    17. LETTERS
    1. Practical coagulation for the blood banker (pages 1594–1602)

      Maureane Hoffman and Lisa J.H. Cichon

      Article first published online: 8 APR 2013 | DOI: 10.1111/trf.12201

  16. LETTERS

    1. Top of page
    2. EDITORIAL
    3. TRANSFUSION MEDICINE ILLUSTRATED
    4. CLINICAL RESEARCH FOCUS #34
    5. HOW DO I … ?
    6. TRANSFUSION COMPLICATIONS
    7. TRANSFUSION PRACTICE
    8. BLOOD DONORS AND BLOOD COLLECTION
    9. BLOOD MANAGEMENT
    10. DONOR INFECTIOUS DISEASE TESTING
    11. TRANSPLANTATION AND CELLULAR ENGINEERING
    12. BLOOD COMPONENTS
    13. BLOOD GROUP GENOMICS
    14. IMMUNE HEMATOLOGIC DISEASE
    15. HEMAPHERESIS
    16. REVIEWS
    17. LETTERS
    1. In reply (page 1621)

      Eldad A. Hod

      Article first published online: 11 JUL 2013 | DOI: 10.1111/trf.12262

    2. Biospecimen Reporting for Improved Study Quality (BRISQ) (page e1)

      Helen M. Moore, Andrea Kelly, Lisa M. McShane and Jim Vaught

      Article first published online: 11 JUL 2013 | DOI: 10.1111/trf.12281

SEARCH

SEARCH BY CITATION